BCDA

BioCardia, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 7/12/2017
Contact Info
  • 125 Shoreway Road
  • Suite B
  • San Carlos, CA 94070

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0000925741
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3842 - Surgical appliances and supplies
Incorporated In: DE, USA
Year of Inc. 1994
Employees Not Available
Company Officers/Contacts
Peter Alan Altman CEO, President
David McClung VP, Fin.
Henricus Johannes Duckers CMO
Ivone Chanu Manager
Richard Thomas Allen Other
Company Directors
Simon H. Stertzer Chairman, Independent Director
Peter Alan Altman
Fernando L. Fernandez Independent Director, Audit Committee Member
Richard Pfenniger, Jr. Independent Director, Compensation Committee Member
Richard M. Krasno Independent Director
Jay M. Moyes Independent Director, Audit Committee Member, Compensation Committee Member
Thomas Quertermous Independent Director
Allan Roger Tessler Independent Director, Audit Committee Member
Service Providers
Accounting/Auditing Firm
KPMG
55 Second Street, Suite 1400
San Francisco, CA, 94105
United States
 
Securities Counsel
Wilson Sonsini Goodrich & Rosati
12235 El Camino Real
San Diego, CA, 92130
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Tiger X Medical, Inc. until 10-2016
  • Formerly=Cardo Medical, Inc. until 7-2011
  • Formerly=clickNsettle.com, Inc. until 11-2008
  • Formerly=NAM Corp. until 6-00
BCDA Security Details
Share Structure
Market Value1 $206,388,763 a/o Oct 19, 2017
Authorized Shares 750,000,000 a/o Oct 19, 2017
Outstanding Shares 458,641,696 a/o Oct 19, 2017
-Restricted 381,164,064 a/o Oct 19, 2017
-Unrestricted 77,477,632 a/o Oct 19, 2017
Held at DTC 41,314,016 a/o Oct 19, 2017
Float 41,118,229 a/o Jul 19, 2017
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
Continental Stock Transfer & Trust Company
Shareholders
Shareholders of Record 307 a/o Jul 19, 2017
Short Selling Data
Short Interest 22,435 (270.89%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security